Healthcare & Biotech

SHERIDAN, WYOMING - December 2, 2025 - Microbial fermentation is moving back to the center of biologics manufacturing strategy, and contract development and manufacturing organizations (CDMOs) like AGC Biologics are under pressure to turn the platform's greatest strength-speed-into a reproducible, industrial-scale advantage.

Microbial fermentation's resurgence - and its speed problem

Microbial systems have long been valued for fast, efficient production of biologics, and they are now seeing renewed interest for a new generation of therapies. Yet the same speed that makes microbial fermentation attractive also makes it unforgiving. Typical production runs last around 48 hours, leaving very little time to diagnose and correct process deviations once a run is underway.

SHERIDAN, WYOMING - December 2, 2025 - As several large pharmas pull back from cell therapy, a core group of biopharma players is doubling down on CAR T and next-generation approaches, positioning themselves to capture long-term value in oncology and autoimmune disease even as near-term sentiment cools.

Big pharma exits reshape expectations, not potential

Over the past year, the cell therapy field has seen a string of high-profile retreats. Takeda halted new investments in the modality and is offloading its pipeline and platforms after more than eight years of heavy spending. Novo Nordisk followed by terminating all cell therapy work, including a type 1 diabetes program, with nearly 250 roles cut. Belgian biotech Galapagos also shut down its cell therapy business after failing to find a buyer.

SHERIDAN, WYOMING - December 2, 2025 - A wave of first-in-class hereditary angioedema (HAE) therapies is reshaping the U.S. Biotech & Research landscape, but questions remain over how quickly clinicians and patients will adopt these options in an already well-served rare disease market.

New approvals expand hereditary angioedema treatment choices

The HAE pipeline has accelerated dramatically, moving from basic C1 esterase inhibitors to sophisticated RNA-targeting and gene-editing approaches. The disease's life-threatening swelling attacks, including airway involvement, have long justified investment in both acute and prophylactic care, with the first FDA-approved preventive and on-demand therapies arriving in 2008 and 2009.

SHERIDAN, WYOMING - December 2, 2025 - As the United States grapples with record-setting government shutdowns and budget fights, the country's biotech and research ecosystem is confronting a deeper structural problem: federal science funding is increasingly unstable, putting early-stage innovation, talent pipelines and long-term competitiveness at risk. For an industry built on long horizons and high-risk discovery, interruptions to programs such as NIH grants and Small Business Innovation Research (SBIR) contracts are more than a temporary setback-they threaten the foundations of America's leadership in biopharma innovation.

Federal science funding as the backbone of U.S. biopharma

SHERIDAN, WYOMING - November 25, 2025 - Royal Philips has launched Image Management 15, the next generation of its Philips Vue PACS platform, featuring a zero-footprint web diagnostic viewer that brings full radiology workstation capabilities into a standard web browser. Positioned as a cornerstone of Philips' cloud-enabled imaging informatics strategy, the solution is designed to help health systems modernize remote reading, streamline AI integration, and simplify IT across distributed radiology networks.

Anywhere, anytime diagnostic reading via the browser

The new web-based diagnostic viewer is built to address one of radiology's most persistent pain points: lost clinical time due to slow performance and fragmented remote reading setups. Delivering high-performance server-side rendering and workflow automation, it allows radiologists to access advanced clinical tools securely through a browser, without local installation.

SHERIDAN, WYOMING - November 25, 2025 - Royal Philips has extended its partnership with quantitative neuroimaging specialist Cortechs.ai to integrate advanced AI-enabled neuroimaging analytics directly into Philips MR systems, giving radiologists faster, more objective and reproducible insights into brain health within their everyday workflows. By combining Philips' next-generation MR technologies with Cortechs.ai's quantitative post-processing software, the collaboration aims to set a new benchmark for precision diagnostics in neurology and strengthen Philips' position in data-driven brain imaging.

Meeting surging demand for brain MR with data-driven insight

SHERIDAN, WYOMING - November 25, 2025 - Royal Philips is introducing DeviceGuide, an AI-powered device tracking solution that brings real-time, 3D navigation support into one of interventional cardiology's most demanding procedures: minimally invasive repair of leaking heart valves. Built on the company's EchoNavigator platform and previewed at London Valves 2025, DeviceGuide is designed to translate complex imaging into intuitive visual guidance, helping structural heart teams perform mitral valve repair with greater clarity, confidence and reproducibility.

AI-guided navigation inside the procedure room

SHERIDAN, WYOMING - November 25, 2025 - In radiology, the most transformative AI of the coming decade may not be the algorithms that make headlines, but the ones that quietly shave minutes off every case, reduce clicks, and keep worklists flowing smoothly for overburdened imaging teams. That is the vision outlined by Shez Partovi, MD, Chief Innovation Officer and Chief Business Leader Enterprise Informatics at Philips, who argues that the future of AI in radiology is the AI you barely notice - deeply embedded into workflows rather than bolted on as yet another standalone tool.

From "Will it help?" to "How fast can you implement it?"

SHERIDAN, WYOMING - November 25, 2025 - Philips has received U.S. FDA 510(k) clearance for the latest release of its Cardiovascular Workspace (IntelliSpace Cardiovascular, ISCV), enabling U.S. health systems to deploy the cardiovascular imaging and information management platform as a cloud-hosted, SaaS solution on Philips HealthSuite. The move positions hospitals and cardiology networks to modernize IT, scale integrated diagnostics, and accelerate real-world adoption of AI-enabled cardiovascular workflows.

Cloud-based cardiovascular informatics for U.S. health systems

SHERIDAN, WYOMING - November 25, 2025 - Nestlé Health Science is deepening its open innovation strategy in nutrition and health through a series of academic and startup collaborations focused on women's health, healthy longevity and weight management, positioning itself at the center of fast-growing therapeutic nutrition markets. By linking university-based science, entrepreneurial talent and its own R&D capabilities, the company aims to accelerate the translation of emerging technologies into differentiated nutritional solutions for consumers and patients.